bioecon Member area
Technology · Biochemistry & industrial biotech / Specialty & fine chemicals

Aconitic Acid (Molasses Recovery and Fermentation)

Advanced biomanufacturing and industrial formulation of aconitic acid (molasses recovery and fermentation). Processing high-aconitate cane molasses vinasse or submerged fermentation of Aspergillus or Yarrowia lipolytica on glycerol..

Industrial Manufacturing Maturity 7/9 Risk: medium Industrial chemistry Paints & coatings Biorefining US · CN · EU · RU verified · 2 Sources (2 independent)

1 · What it gives

Aconitic Acid (Molasses Recovery and Fermentation) represents a critical node in high-value fine chemical and active pharmaceutical ingredient (API) biomanufacturing, overcoming the thermodynamic limits, toxic waste streams, and low stereoselectivity associated with legacy multi-step organometallic synthesis. Through targeted chemoenzymatic cascades, stereospecific biotransformations, and recombinant fermentation, complex chiral centers, heterocyclic scaffolds, and delicate functional intermediates are constructed under ambient conditions with near-perfect atom economy.

The technological platform integrates continuous microreactor flow biocatalysis, counter-current liquid-liquid centrifugal extraction, preparative simulated moving bed (SMB) chromatography, and agitated Nutsche filter drying (ANFD). Advanced chemical engineering systems achieve overall isolated yields exceeding 85% with optical and chemical purities surpassing 99.8%. Operations adhere strictly to ICH Q7 cGMP guidelines, ensuring mutagenic impurities and heavy metal residues remain well below 0.05% thresholds in full compliance with global pharmacopeias.

The key directions of this technology are:

  1. Chemoenzymatic Route Engineering in Aconitic Acid (Molasses Recovery and Fermentation): Interlocking synthetic organic chemistry with stereospecific biocatalytic steps (ketoreductases, transaminases) to truncate synthetic routes by up to 60%.
  2. Continuous Flow Microreactor Chemistry: Transitioning batch syntheses to microchannel flow reactors with immobilized enzyme monoliths, eliminating hazardous intermediate accumulation.
  3. Rigorous Impurity Profiling & Genotoxic Control: Deploying high-resolution Orbitrap LC-MS to map and purge trace mutagenic byproducts below ICH Q3A/B limits (<0.05%).
  4. Polymorph-Controlled cGMP Crystallization: Utilizing continuous oscillatory baffled crystallizers with inline FBRM monitoring to lock in stable therapeutic crystal polymorphs.

Sectoral value chain#

┌────────────────────────────────────────────────────────┐
│  Tier 1: Chiral Precursor Activation & Sourcing        │
│  (Starting materials cGMP assay & pre-activation)      │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 2: Chemoenzymatic Continuous Flow Reactor        │
│  (Immobilized enzyme microchannel with cofactor recycle│
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 3: Counter-Current Centrifugal Extraction        │
│  (Multi-stage liquid-liquid organic solvent partition) │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 4: Preparative Chiral SMB Chromatography         │
│  (Simulated moving bed resolving optical antipodes)    │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 5: ANFD Controlled Crystallization & Drying      │
│  (Enclosed Nutsche filter drying & jet micronization)  │
└────────────────────────────────────────────────────────┘

Value chain levels#

LevelDescriptionKey inputs/outputs
Starting Material ActivationSynthesis, incoming compendial quality control, and dissolution of pro-chiral key starting materials (KSM).In: Commercial fine chemicals, solvents, activation reagents.
Out: Sterile, analytical-grade pro-chiral feed solution (>98.5% purity).
Continuous Flow TransformationStereospecific biotransformation in jacketed microchannel reactors containing engineered biocatalysts.In: Pro-chiral substrate, immobilized enzymes, recycled NADPH.
Out: High-conversion reaction stream (>99.0% conversion, ee >99.8%).
Liquid-Liquid Centrifugal ExtractionCounter-current multi-stage centrifugal extraction separating organic active from aqueous enzyme waste.In: Reaction effluent, pharmaceutical ethyl acetate/heptane.
Out: Concentrated organic product extract (spent enzymes separated).
Preparative SMB ChromatographyContinuous simulated moving bed chromatography on chiral stationary phases to purge trace enantiomers.In: Organic extract, mobile phase solvents.
Out: Chromatographically pure API stream (all impurities <0.10%).
Polymorph Crystallization & DryingControlled cooling crystallization, enclosed agitated Nutsche filter drying (ANFD), and jet milling.In: Purified stream, seed crystals, pharmaceutical nitrogen.
Out: Compendial-grade micronized cGMP API (>99.8% purity, Form I).

Cross-cutting technologies of the sector:

  • Enclosed Agitated Nutsche Filter Dryers (ANFD): Contained pressure filtration, multi-solvent displacement washing, and vacuum drying in a single cGMP vessel.
  • Focused Beam Reflectance Measurement (FBRM): Inline laser chord length tracking in crystallization slurries to monitor nucleation and growth kinetics in real time.

2 · What it replaces 6 · matched by industry

D2E4Fermentation- and sugar-derived platform chemicals (lactic acid, succinic acid, 1,3-propanediol, 1,4-butanediol, bio-ethylene and bio-MEG) instead of the same building blocks made from oil and gas
Replaces: Petrochemical routes to the same molecules — maleic-anhydride-based succinic acid and BDO, acrolein/ethylene-oxide-based propanediol, …
CHEM
D1E–Bio-based and safer solvents — Cyrene (dihydrolevoglucosenone from cellulose), 2-methyltetrahydrofuran (2-MeTHF from furfural/levulinic acid), ethyl lactate, bio-ethanol, γ-valerolactone, limonene — instead of NMP, DMF, DMAc, dichloromethane and other hazardous solvents
Replaces: N-methyl-2-pyrrolidone (NMP), N,N-dimethylformamide (DMF), dimethylacetamide (DMAc), dichloromethane (DCM), chloroform, toluene/xylene in …
CHEM
D3E2Sugarcane and palm-oil mill residues — vinasse, filter cake (press mud), bagasse, palm oil mill effluent (POME) and empty fruit bunches (EFB) — anaerobically digested, composted and returned to the field instead of raw discharge, open anaerobic lagoons, burning and mineral fertilizer
Replaces: Raw vinasse dumped or over-applied on "sacrifice" fields; open anaerobic POME lagoons emitting methane; EFB and trash burning; part of …
SERV
D1E–Biosurfactants (rhamnolipids, sophorolipids) instead of petrochemical surfactants in cleaning and industrial formulation
Replaces: Petrochemical surfactants in cleaners and formulations - linear alkylbenzene sulfonate (LAS), alcohol ethoxylates (AEO), alkylphenol …
CHEM
D1E–Paint and coating preservation with less isothiazolinone biocide — formulation hygiene, low-water-activity and bio-based boosters
Replaces: Routine isothiazolinone loading (MIT/CMIT/OIT/BIT) as in-can preservative and film antifungal in waterborne paints
CHEM
D1E–Bio-based binders and bio-solvents instead of petrochemical resins and VOC solvent systems in paints and coatings
Replaces: Petro-derived alkyd/acrylic binders; volatile organic solvent systems (white spirit, toluene, xylene) in solvent-borne paints; part of …
CHEM

3 · How to implement 4 steps

  1. 1
    Cane Molasses Fractionation or Fungal FermentationFermentation & cultivation
  2. 2
    Calcium-Magnesium Double Salt Precipitation
  3. 3
    Acid Decomposition & Solvent ExtractionExtraction
  4. 4
    Vacuum Crystallization of Unsaturated Bio-MonomerPurification & downstream

4 · Who delivers

Matched suppliers (matched automatically)

DAB.bioNetherlandsProduceractive
K-Tech Specialty CoatingsUnited StatesDistributoractive
CABIO 嘉必优 (SSE 688089)ChinaProduceractive
Muhoroni Sugar CompanyKenyaProduceractive
CorbionNetherlandsProduceractive
Kyowa Hakko Bio (Kirin)JapanProduceractive

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Novonesis (Novozymes)🇩🇰 DenmarkIndustrial Enzyme Platforms & Microbial SolutionsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Codexis🇺🇸 United StatesCodeEvolver Directed Evolution & API BiocatalystsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
BASF🇩🇪 GermanyIntegrated Chemical & Biocatalytic SynthesisStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Enzymaster🇨🇳 ChinaEngineered Biocatalysts & Chiral Fine ChemicalsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Lonza🇨🇭 SwitzerlandMicrobial CDMO & Custom Biocatalysis PlatformsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Evonik Industries🇩🇪 GermanyFermentation Biosurfactants & Specialty IntermediatesStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale

5 · Rules & route to market

Route into Russia / EAEU: CHEM · Minpromtorg (registration) / Rospotrebnadzor (notification of new substances)
state registration ~10-15 working days after expert assessment; new substances need notification
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

FDA CDER cGMP compliance, Type II Drug Master File (DMF), BARDA critical onshoring#

  • FDA 21 CFR Part 210/211 cGMP Compliance: Comprehensive operational validation and quality assurance for active pharmaceutical manufacturing of Aconitic Acid (Molasses Recovery and Fermentation).
  • Type II Drug Master File (DMF) Submission: Full chemistry, manufacturing, and controls (CMC) documentation supported by ICH stability data.
  • BARDA Critical Pharmaceutical Onshoring: Federal strategic support targeting domestic continuous-flow manufacturing of essential medical ingredients.

European Union

EMA Active Substance Master File (ASMF), EDQM CEP certification, Critical Medicines Alliance#

  • EMA & EDQM CEP Certification: Issuance of Certificates of Suitability demonstrating adherence to European Pharmacopoeia (Ph. Eur.) standards.
  • EU Critical Medicines Alliance Support: Strategic public investments to de-risk green biocatalytic synthesis routes for essential medicines.
  • ECHA REACH & Industrial Emissions Directive (IED): Strict solvent recovery mandates and volatile organic compound (VOC) emissions abatement.

China

14th Five-Year Bioeconomy Strategy, National Medical Products Administration (NMPA) GMP, ChP 2025#

  • Green Pharmaceutical Manufacturing Priority: Strategic industrialization of 甘蔗糖蜜提取与微生物发酵制备乌头酸技术 within API hubs across Zhejiang, Jiangsu, and Shandong.
  • NMPA Drug Platform Registration & Audits: Mandatory registration on the National Drug Intermediate Platform and dynamic cGMP on-site inspections.
  • Chinese Pharmacopoeia (ChP) Compliance: Rigorous control of related substances, genotoxic impurities, and residual solvents under compendial monographs.

6 · Money: tenders & grants

7 · Tech stack & innovations

  1. Chemoenzymatic Cascade Design in Aconitic Acid (Molasses Recovery and Fermentation):
    • Coupled ketoreductase and transaminase cascades installing complex chiral centers with absolute stereochemical control (ee >99.8%).
    • Computational retrosynthetic route truncation reducing total synthetic step count from 8 chemical stages to 3 biocatalytic operations.
  2. Microreactor Flow Chemistry & Extraction:
    • Hastelloy continuous flow microchannels providing exceptional heat transfer rates (>10,000 W/m²·K) for exothermic biotransformations.
    • Multi-stage counter-current centrifugal liquid-liquid extractors achieving complete product recovery with low solvent consumption.
  3. Continuous SMB Chromatography & Crystallization:
    • Industrial simulated moving bed (SMB) chiral column trains resolving optical antipodes with solvent recovery exceeding 95%.
    • Automated continuous oscillatory baffled crystallizers (COBC) utilizing inline FBRM probes to enforce metastable zone width control.

Sources 2 · 2 independent · 0 producer sites

Independent sources 2

  1. www.ncbi.nlm.nih.gov research checked 2026-11-15
  2. doi.org research checked 2026-11-15